$ALTO
Alto Ingredients, Inc.

2024 Q3 Form 10-Q Financial Statement

#000121390024066660 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $251.8M $236.5M $317.3M
YoY Change -20.84% -25.47% -12.39%
Cost Of Revenue $245.9M $228.9M $300.1M
YoY Change -21.69% -23.72% -15.06%
Gross Profit $5.960M $7.553M $17.18M
YoY Change 43.23% -56.04% 94.27%
Gross Profit Margin 2.37% 3.19% 5.41%
Selling, General & Admin $7.510M $8.961M $7.911M
YoY Change -11.52% 13.27% -12.06%
% of Gross Profit 126.01% 118.64% 46.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.058M $6.075M $5.680M
YoY Change 7.41% 6.95% -15.58%
% of Gross Profit 101.64% 80.43% 33.06%
Operating Expenses $7.510M $8.961M $7.911M
YoY Change -11.52% 13.27% -12.06%
Operating Profit -$720.0K -$1.408M $9.270M
YoY Change -83.36% -115.19% -6198.68%
Interest Expense -$1.867M -$1.669M -$1.734M
YoY Change -6.65% -3.75% 443.57%
% of Operating Profit -18.71%
Other Income/Expense, Net $146.0K -$29.00K $59.00K
YoY Change 461.54% -149.15% -189.39%
Pretax Income -$2.441M -$3.106M $7.595M
YoY Change -30.04% -140.9% -65.66%
Income Tax
% Of Pretax Income
Net Earnings -$2.441M -$3.106M $7.595M
YoY Change -30.04% -140.9% -65.66%
Net Earnings / Revenue -0.97% -1.31% 2.39%
Basic Earnings Per Share -$0.04 -$0.05 $0.10
Diluted Earnings Per Share -$0.04 -$0.05 $0.10
COMMON SHARES
Basic Shares Outstanding 76.49M shares 76.63M shares 76.11M shares
Diluted Shares Outstanding 73.84M shares 73.49M shares 74.10K shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.59M $27.12M $22.74M
YoY Change 28.21% 19.28% -60.37%
Cash & Equivalents $33.59M $27.12M $22.74M
Short-Term Investments
Other Short-Term Assets $6.568M $6.126M $5.919M
YoY Change 5.71% 3.5% -46.58%
Inventory $48.01M $49.43M $71.12M
Prepaid Expenses
Receivables $52.04M $64.08M $63.37M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $145.2M $153.7M $179.5M
YoY Change -13.71% -14.41% -34.36%
LONG-TERM ASSETS
Property, Plant & Equipment $238.9M $244.9M $246.7M
YoY Change -4.01% -0.73% 10.65%
Goodwill $5.970M
YoY Change 1.05%
Intangibles $8.057M $8.204M $8.792M
YoY Change -6.8% -6.69%
Long-Term Investments
YoY Change
Other Assets $6.029M $5.339M $5.993M
YoY Change 0.27% -10.91% 7.17%
Total Long-Term Assets $272.3M $278.8M $291.9M
YoY Change -7.05% -4.47% 13.21%
TOTAL ASSETS
Total Short-Term Assets $145.2M $153.7M $179.5M
Total Long-Term Assets $272.3M $278.8M $291.9M
Total Assets $417.4M $432.5M $471.4M
YoY Change -9.48% -8.25% -11.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.21M $20.13M $25.93M
YoY Change -28.28% -22.37% 20.74%
Accrued Expenses $14.26M $16.50M $15.33M
YoY Change -14.35% 7.67% -28.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $45.10M $49.77M $58.69M
YoY Change -22.79% -15.2% -38.31%
LONG-TERM LIABILITIES
Long-Term Debt $83.34M $90.96M $82.08M
YoY Change 9.84% 10.82% 56.29%
Other Long-Term Liabilities $9.302M $9.120M $8.791M
YoY Change 4.87% 3.74% -14.55%
Total Long-Term Liabilities $92.64M $100.1M $90.87M
YoY Change 9.32% 10.13% 44.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.10M $49.77M $58.69M
Total Long-Term Liabilities $92.64M $100.1M $90.87M
Total Liabilities $153.5M $166.7M $170.6M
YoY Change -5.9% -2.31% 1.72%
SHAREHOLDERS EQUITY
Retained Earnings -$782.1M -$779.4M -$740.8M
YoY Change 5.03% 5.2% 10.1%
Common Stock $77.00K $77.00K $76.00K
YoY Change 1.32% 1.32% 2.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $263.9M $265.8M $300.8M
YoY Change
Total Liabilities & Shareholders Equity $417.4M $432.5M $471.4M
YoY Change -9.48% -8.25% -11.28%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$2.441M -$3.106M $7.595M
YoY Change -30.04% -140.9% -65.66%
Depreciation, Depletion And Amortization $6.058M $6.075M $5.680M
YoY Change 7.41% 6.95% -15.58%
Cash From Operating Activities $18.57M -$13.73M $10.44M
YoY Change -19.72% -231.46% 8.43%
INVESTING ACTIVITIES
Capital Expenditures $491.0K $4.654M $8.366M
YoY Change -92.61% -44.37% -212.63%
Acquisitions
YoY Change
Other Investing Activities $400.0K -$1.400M $0.00
YoY Change
Cash From Investing Activities -$91.00K -$6.054M -$8.366M
YoY Change -98.63% -27.64% 12.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.394M 6.121M -3.423M
YoY Change 24.91% -278.82% -127.27%
NET CHANGE
Cash From Operating Activities 18.57M -13.73M 10.44M
Cash From Investing Activities -91.00K -6.054M -8.366M
Cash From Financing Activities -8.394M 6.121M -3.423M
Net Change In Cash 10.08M -13.66M -1.346M
YoY Change 3.2% 914.93% -109.12%
FREE CASH FLOW
Cash From Operating Activities $18.57M -$13.73M $10.44M
Capital Expenditures $491.0K $4.654M $8.366M
Free Cash Flow $18.08M -$18.38M $2.077M
YoY Change 9.62% -985.03% -87.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-21467
dei Entity Registrant Name
EntityRegistrantName
ALTO INGREDIENTS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-2170618
dei Entity Address Address Line1
EntityAddressAddressLine1
1300 South Second Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Pekin
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
61554
dei City Area Code
CityAreaCode
(916)
dei Local Phone Number
LocalPhoneNumber
403-2123
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
ALTO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
76486169 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27124000 usd
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1287000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
64081000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
49434000 usd
CY2024Q2 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
5606000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
6126000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
153658000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
244893000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20404000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8204000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5339000 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
33947000 usd
CY2024Q2 us-gaap Assets
Assets
432498000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
20132000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16504000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4481000 usd
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2764000 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5886000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
49767000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
90960000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16828000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9120000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
166675000 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
18075000 usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76645000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76645000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
77000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1042639000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2481000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-779375000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
265823000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
432498000 usd
CY2024Q2 us-gaap Revenues
Revenues
236468000 usd
CY2023Q2 us-gaap Revenues
Revenues
317297000 usd
us-gaap Revenues
Revenues
477097000 usd
us-gaap Revenues
Revenues
631188000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
228915000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
300116000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
471944000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
617171000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
7553000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
17181000 usd
us-gaap Gross Profit
GrossProfit
5153000 usd
us-gaap Gross Profit
GrossProfit
14017000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8961000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7911000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16893000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15793000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
574000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1408000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
9270000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11740000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2350000 usd
CY2024Q2 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
1669000 usd
CY2023Q2 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
1734000 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
3303000 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
3299000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-29000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
59000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
212000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
78000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3106000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7595000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14831000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5571000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-3106000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
7595000 usd
us-gaap Net Income Loss
NetIncomeLoss
-14831000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5571000 usd
CY2024Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
316000 usd
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
315000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
631000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
627000 usd
CY2023Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
96000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3422000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7184000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15462000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6198000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73486000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73394000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73126000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73603000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73486000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74103000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73126000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73603000 shares
us-gaap Net Income Loss
NetIncomeLoss
-14831000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5571000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
11802000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
11735000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
11570000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
5174000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
574000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2788000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1711000 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
505000 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
494000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
400000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
397000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-47000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-46000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5305000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5334000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7014000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4487000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3701000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3565000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2901000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2566000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3855000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-18870000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12299000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12904000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9297000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17968000 usd
alto Deferred Purchase Price Payments
DeferredPurchasePricePayments
2800000 usd
alto Deferred Purchase Price Payments
DeferredPurchasePricePayments
3500000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12097000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21468000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
7958000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
13247000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2683000 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
631000 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
627000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7327000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9937000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-17069000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-24435000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45480000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49525000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28411000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25090000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27124000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22739000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1287000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2351000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28411000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25090000 usd
us-gaap Interest Paid Net
InterestPaidNet
4080000 usd
us-gaap Interest Paid Net
InterestPaidNet
3964000 usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
1725000 usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
1615000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
279557000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1142000 usd
CY2024Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
315000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-11725000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
268659000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1646000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1060000 usd
CY2024Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
316000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-3106000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
265823000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
308089000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
752000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-6000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1682000 usd
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
312000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-13166000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
293675000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
959000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-120000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1001000 usd
CY2023Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
315000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
7595000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
300793000 usd
CY2024Q2 alto Production Capacity
ProductionCapacity
350000000 gal
alto Essential Ingredient Product Capacity
EssentialIngredientProductCapacity
1600000 t
CY2024Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
59135000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
51315000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
26000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
85000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
20000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
7000 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
47000 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
46000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Estimates and Assumptions</span></i> – The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are required as part of determining the allowance for credit losses, net realizable value of inventory, long-lived asset impairments, valuation allowances on deferred income taxes, the potential outcome of future tax consequences of events recognized in the Company’s financial statements or tax returns, and the valuation of assets acquired and liabilities assumed as a result of business combinations. Actual results and outcomes may materially differ from management’s estimates and assumptions.</span></p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 pure
CY2024Q2 us-gaap Revenues
Revenues
236468000 usd
CY2023Q2 us-gaap Revenues
Revenues
317297000 usd
us-gaap Revenues
Revenues
477097000 usd
us-gaap Revenues
Revenues
631188000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
228915000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
300116000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
471944000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
617171000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
7553000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
17181000 usd
us-gaap Gross Profit
GrossProfit
5153000 usd
us-gaap Gross Profit
GrossProfit
14017000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3106000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7595000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14831000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5571000 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6075000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5681000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11802000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11735000 usd
CY2024Q2 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
1669000 usd
CY2023Q2 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
1734000 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
3303000 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
3299000 usd
CY2024Q2 us-gaap Assets
Assets
432498000 usd
CY2023Q4 us-gaap Assets
Assets
454241000 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2201000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
29201000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
35765000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
4480000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
5063000 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
10079000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10313000 usd
CY2024Q2 us-gaap Other Inventory
OtherInventory
5674000 usd
CY2023Q4 us-gaap Other Inventory
OtherInventory
1470000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
49434000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
52611000 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-8231000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-6951000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
11570000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
5174000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
98648000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
90690000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3493000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3893000 usd
CY2024Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
4195000 usd
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
4700000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
90960000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
82097000 usd
CY2024Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
30300000 usd
CY2024Q2 alto Line Of Credit Facility Available For Capital Improvement Project
LineOfCreditFacilityAvailableForCapitalImprovementProject
65000000 usd
CY2024Q2 us-gaap Significant Supply Commitment Remaining Minimum Amount Committed
SignificantSupplyCommitmentRemainingMinimumAmountCommitted
4795000 usd
alto Indexed Price Sales Contract
IndexedPriceSalesContract
59000 t
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
7783000 usd
CY2023Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
20897000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-3106000 usd
CY2024Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
316000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3422000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73486000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
7595000 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
315000 usd
CY2023Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
96000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7184000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73394000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
709000 shares
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
7184000 usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74103000 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
us-gaap Net Income Loss
NetIncomeLoss
-14831000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
631000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15462000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73126000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Net Income Loss
NetIncomeLoss
-5571000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
627000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6198000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73603000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
usd
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73486000 shares
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3422000 usd
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q2 us-gaap Dilutive Securities
DilutiveSecurities
usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-15462000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73126000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73603000 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6198000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000778164

Files In Submission

Name View Source Status
0001213900-24-066660-index-headers.html Edgar Link pending
0001213900-24-066660-index.html Edgar Link pending
0001213900-24-066660.txt Edgar Link pending
0001213900-24-066660-xbrl.zip Edgar Link pending
alto-20240630.xsd Edgar Link pending
ea0210585-10q_altoingred.htm Edgar Link pending
ea021058501ex31-1_altoingred.htm Edgar Link pending
ea021058501ex31-2_altoingred.htm Edgar Link pending
ea021058501ex32-1_altoingred.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
alto-20240630_def.xml Edgar Link unprocessable
alto-20240630_lab.xml Edgar Link unprocessable
alto-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0210585-10q_altoingred_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
alto-20240630_cal.xml Edgar Link unprocessable